These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33740437)

  • 1. Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.
    Colhoun HM; McGurnaghan SJ; McKeigue PM
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):201. PubMed ID: 33740437
    [No Abstract]   [Full Text] [Related]  

  • 2. Microvascular disease in diabetes and severe COVID-19 outcomes.
    Corcillo A; Whyte MB; Vas P; Karalliedde J
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):200-201. PubMed ID: 33740436
    [No Abstract]   [Full Text] [Related]  

  • 3. Observational research on severe COVID-19 in diabetes.
    Stehouwer CDA
    Lancet Diabetes Endocrinol; 2021 Feb; 9(2):56-57. PubMed ID: 33357490
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of diabetes in patients with COVID-19 - Authors' reply.
    Bornstein SR; Zimmet P; Rubino F; Ludwig B
    Lancet Diabetes Endocrinol; 2020 Aug; 8(8):669-670. PubMed ID: 32707113
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive drugs and risk of COVID-19? - Authors' reply.
    Fang L; Karakiulakis G; Roth M
    Lancet Respir Med; 2020 May; 8(5):e32-e33. PubMed ID: 32222169
    [No Abstract]   [Full Text] [Related]  

  • 6. The ability of the neonatal immune response to handle SARS-CoV-2 infection - Authors' reply.
    Gale C; Quigley MA; Placzek A; Knight M; Ladhani S; Draper ES; Sharkey D; Doherty C; Mactier H; Kurinczuk JJ
    Lancet Child Adolesc Health; 2021 Mar; 5(3):e8. PubMed ID: 33484657
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply.
    Yang K; Sheng Y; Wu B; Wu G
    Lancet Oncol; 2020 Sep; 21(9):e408. PubMed ID: 32888458
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward a clinically based classification of disease severity for paediatric COVID-19 - Authors' reply.
    Chen D; Tang F; Lu S; Song Q
    Lancet Infect Dis; 2021 Jan; 21(1):22-23. PubMed ID: 32422200
    [No Abstract]   [Full Text] [Related]  

  • 9. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Sathish T; de Mello GT; Cao Y
    J Diabetes; 2021 Feb; 13(2):177-178. PubMed ID: 33107708
    [No Abstract]   [Full Text] [Related]  

  • 10. Instrumental dead space in ventilator management - Authors' reply.
    Schultz MJ; Bos LDJ; Paulus F; Neto AS
    Lancet Respir Med; 2021 Mar; 9(3):e23. PubMed ID: 33524317
    [No Abstract]   [Full Text] [Related]  

  • 11. Frailty and mortality in patients with COVID-19 - Authors' reply.
    McCarthy K; Hewitt J; Myint PK; Quinn T; Carter B
    Lancet Public Health; 2020 Nov; 5(11):e582. PubMed ID: 33120043
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations.
    Patoulias D; Katsimardou A; Papadopoulos C; Doumas M
    Acta Diabetol; 2021 Jan; 58(1):125-126. PubMed ID: 32816107
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Lippi G; Sanchis-Gomar F; Henry BM
    J Diabetes; 2021 Feb; 13(2):179-180. PubMed ID: 33128349
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucovigilance in COVID-19.
    Lamptey R; Ahomagnon S; Acheampong F; Kalra S
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.
    Dhar SK; Sachdeva K; Das M
    Diabetes Metab Syndr; 2021; 15(2):639-641. PubMed ID: 33676871
    [No Abstract]   [Full Text] [Related]  

  • 17. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
    Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
    Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Vaccine in Children: Where Do We Stand?: Authors' Reply.
    Kasi SG; Shah A
    Indian Pediatr; 2021 Feb; 58(2):195. PubMed ID: 33632967
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Adhikari EH; Moreno W; Zofkie AC; MacDonald L; McIntire DD; Collins RRJ; Spong CY
    JAMA Netw Open; 2020 Nov; 3(11):e2029256. PubMed ID: 33211113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.